Allele Biotechnology
Allele Biotechnology is a pioneering provider of cGMP-induced pluripotent stem cells (iPSCs) and cell therapy contract development and manufacturing organization (CDMO) services, dedicated to advancing immuno-oncology and regenerative medicine. With over a decade of experience, the company offers a range of solutions from off-the-shelf iPSC lines to custom development, ensuring consistency, scalability, and cost-effectiveness in cell therapy programs.
Utilizing a patented mRNA reprogramming system, Allele generates high-quality iPSCs that are footprint-free, feeder-free, and xeno-free, minimizing potential genomic risks. Their commitment to strict regulatory standards facilitates a smooth transition from scientific development to commercial deployment, making them a comprehensive partner for researchers and biopharma companies alike.
Generated from the website